vimarsana.com
Home
Live Updates
Allurion Technologies, Inc.: First Multi-Center Study Combin
Allurion Technologies, Inc.: First Multi-Center Study Combin
Allurion Technologies, Inc.: First Multi-Center Study Combining the Allurion Program With GLP-1 Therapy Presented at the European Congress on Obesity
Combination therapy led to nearly 19% weight loss at approximately 8 months Allurion, a company dedicated to ending obesity, today announced results from a new study that will be presented at the
Related Keywords
Spain ,
Dublin ,
Ireland ,
Italy ,
Egypt ,
Cedric Damour ,
Gewinn Nur ,
Allurion Program Photo ,
European Congress On Obesity ,
Allurion Program ,
Health Tracker ,
Allurion Gastric Balloon Program ,
European Congress ,
Business Wire ,
Allurion Connected Scale ,
Allurion Gastric Balloon ,
Allurion Virtual Care Suite ,
Allurion Mobile App ,
Allurion Insights ,
Allurion ,
Technologies ,
First ,
Ulti ,
Center ,
Study ,
Combining ,
Program ,
Ith ,
Therapy ,
Resented ,
European ,
Congress ,
Obesity ,